Apyx Medical Corp Interest Expense Nonoperating
Apyx Medical Corp (APYX) reported Interest Expense Nonoperating of $1.39 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-06
- Apyx Medical Corp interest expense nonoperating for the quarter ending 2026-06-30 was $1.39M, a 0.07% increase year-over-year.
- Apyx Medical Corp interest expense nonoperating for the quarter ending 2026-03-31 was $1.37M, a 0.51% decline year-over-year.
- Apyx Medical Corp interest expense nonoperating for the quarter ending 2025-12-31 was $1.41M, a 14.88% decline year-over-year.
- Apyx Medical Corp interest expense nonoperating for the quarter ending 2025-09-30 was $1.41M, a 1.26% decline year-over-year.
- Apyx Medical Corp interest expense nonoperating for fiscal 2025 was $5.59M, a 5.38% decline from fiscal 2024.
- Apyx Medical Corp interest expense nonoperating for fiscal 2024 was $5.91M, a 138.38% increase from fiscal 2023.
- Apyx Medical Corp interest expense nonoperating for fiscal 2023 was $2.48M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.39M 10-Q · filed 2026-08-06 | $2.76M 10-Q · filed 2026-08-06 | $4.17M derived: sum of 3 quarters · filed 2026-08-06 | $5.58M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $1.37M 10-Q · filed 2026-05-07 | $2.78M derived: sum of 2 quarters · filed 2026-05-07 | $4.19M derived: sum of 3 quarters · filed 2026-05-07 | $5.58M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $1.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $2.82M derived: sum of 2 quarters · filed 2026-03-10 | $4.21M derived: sum of 3 quarters · filed 2026-08-06 | $5.59M 10-K · filed 2026-03-10 |
| 2025-09-30 | $1.41M 10-Q · filed 2025-11-06 | $2.81M derived: sum of 2 quarters · filed 2026-08-06 | $4.18M 10-Q · filed 2025-11-06 | $5.83M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $1.39M 10-Q · filed 2026-08-06 | $2.77M 10-Q · filed 2026-08-06 | $4.42M derived: sum of 3 quarters · filed 2026-08-06 | $5.85M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.38M 10-Q · filed 2026-05-07 | $3.03M derived: sum of 2 quarters · filed 2026-05-07 | $4.46M derived: sum of 3 quarters · filed 2026-05-07 | $5.89M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $1.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $3.08M derived: sum of 2 quarters · filed 2026-03-10 | $4.51M derived: sum of 3 quarters · filed 2026-03-10 | $5.91M 10-K · filed 2026-03-10 |
| 2024-09-30 | $1.43M 10-Q · filed 2025-11-06 | $2.86M derived: sum of 2 quarters · filed 2025-11-06 | $4.25M 10-Q · filed 2025-11-06 | $5.37M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $1.43M 10-Q · filed 2025-08-07 | $2.82M 10-Q · filed 2025-08-07 | $3.94M derived: sum of 3 quarters · filed 2025-08-07 | $4.52M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $1.40M 10-Q · filed 2025-05-08 | $2.51M derived: sum of 2 quarters · filed 2025-05-08 | $3.10M derived: sum of 3 quarters · filed 2025-05-08 | |
| 2023-12-31 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $1.70M derived: sum of 2 quarters · filed 2025-03-13 | $2.48M 10-K · filed 2025-03-13 | |
| 2023-09-30 | $585.00K 10-Q · filed 2024-11-08 | $1.36M 10-Q · filed 2024-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |